CRL Charles River Laboratories International, Inc. Common Stock
NYSE · Life Sciences Tools & Services · SEC EDGAR पर देखें ↗ बंद अक्ट 2, 2026 10-K/10-Q अग 5, 2026
$290.19
· 52 सप्ताह की सीमा का %
· निम्न से ऊपर
· उच्च तक
$146.2052w निम्न
$303.3152w उच्च
मार्केट कैप (MRQ)
$13.85B
P/E (TTM)
-60.5
EPS (TTM)
$-4.80
राजस्व (TTM)
$4.00B
आपके बैज
52W रेंज
$146–$303
विश्लेषक रेटिंग
BUY
मूल्य लक्ष्य
$305
P/E
-60.5
ROE
-7.7%
शुद्ध लाभ मार्जिन
-6.0%
आपकी बैज स्ट्रिप खाली है — इस पेज पर कहीं भी एक मीट्रिक पिन करें।
CRL स्टॉक स्नैपशॉट मूल्य, बाजार पूंजीकरण, P/E, EPS, ROE, ऋण/इक्विटी, 52-सप्ताह की सीमा
मूल्य
$290.19
मार्केट कैप (MRQ)
$13.85B
P/E (TTM)
-60.5
EPS (TTM)
$-4.80
राजस्व (TTM)
$4.00B
ROE (TTM)
-7.7%
D/E ऋण/इक्विटी (MRQ)
0.0
52W रेंज
$146–$303
CRL स्टॉक मूल्य चार्ट तकनीकी संकेतकों के साथ दैनिक OHLCV — पैन, ज़ूम और अपना दृश्य कस्टमाइज़ करें
सीमा
बार
बार ग्रैन्युलैरिटी चयनित अवधि के अनुसार अनुकूलित होती है — बार के लिए ओपन/हाई/लो/क्लोज देखने के लिए चार्ट पर होवर करें।
Charles River Laboratories International, Inc. Common Stock के बारे में विकिपीडिया से कंपनी का अवलोकन
Charles River Laboratories International, Incorporated is an American life sciences company and contract research organisation (CRO) headquartered in Wilmington, Massachusetts, United States. Founded in 1947, the company provides goods and services that support the development of drugs, vaccines, and other therapeutics. Its operations span at least 20 countries, offering research models, drug discovery and safety assessment, and manufacturing and testing services to pharmaceutical, biotechnology, government, and other clients.
Charles River Laboratories is a global provider of non-clinical drug development services, known for its role in toxicology studies, research animal models, and microbial testing services used in regulatory submissions to health authorities such as the U.S. Food and Drug Administration (FDA). The company has also been the subject of public scrutiny and regulatory attention over its use of research animals, including dogs, primates, and horseshoe crabs.
As of 2024, the company employs over 20,000 people worldwide and is publicly traded on the New York Stock Exchange under the ticker symbol CRL.
History
Charles River was founded in 1947 by Henry Foster, a young veterinarian who purchased one thousand rat cages from a Virginia farm and set up a one-person laboratory in Boston overlooking the Charles River. He supplied local researchers with laboratory animals.
In 1955, the company's headquarters were relocated to their current home in Wilmington, Massachusetts. The organization became an international entity in 1966 by opening a new animal production facility in France.
The first commercial, comprehensive genetic monitoring program was implemented by Charles River in 1981. Three years later, they were acquired by Bausch & Lomb. In 1988, the organization began creating transgenic mice and rats. In the 1990s, they began in vitro endotoxin testing. In the 1990s, Jim Foster bought Charles River back from Bausch & Lomb, and the company later went public on the New York Stock Exchange.
Charles River launched the Humane Care Imperative in 2002, designed to raise awareness and train employees on animal welfare's importance. The same year, they were named "Company of the Year" by The Boston Globe. The company introduced preconditioning services in 2005 to provide customers with study-ready animals.
In 2008, Charles River signed a ten-year contract to partner with the National Cancer Institute and opened a facility in Frederick, Maryland.
In April 2019, Charles River announced it would cease its San Diego operations, moving the breeding of rodents for testing compounds to Hollister, California.
In March 2023, the Born Free USA animal welfare organization protested against Charles River's plan to export 1,000 endangered juvenile long-tail macaques to Cambodia for testing.
Acquisitions
In 1988, Charles River purchased Specific Pathogen Antigen Free Avian Services (SPAFAS) and serologic diagnostic services Merck, Sharp, and Dohme.
Between 1996 and 2000, the company acquired Endosafe, Inc. and Sierra Biomedical.
In October 2003, Charles River Laboratories merged with Inveresk, a research company based in the United Kingdom. The company was known then as Charles River Laboratories. Inveresk specialised in clinical research and pre-clinical testing, and their main facilities are in Edinburgh, Scotland. In late 2009, Charles River sold its Clinical Services Division in Edinburgh to Quotient Bioresearch.
In 2010, Charles River Laboratories attempted to acquire WuXi PharmaTech, a China-based contract research organization, but the offer was withdrawn when the deal faced opposition from several large Charles River investors, including Relational Investors, JANA Partners, and Neuberger Berman. The proxy advisory firm RiskMetrics had also recommended that Charles River's shareholders vote against the proposed deal.
From 2008 to 2013, Charles River acquires several companies including NewLab Bioquality AG, MIR Preclinical Services, Piedmont Research Center, LLC, Cerebricon, Ltd., Accugenix, and Vital River, allowing the company to expand their research models and services portfolio to drug development and discovery markets in China.
The acquisitions of Argenta and BioFocus in 2014 allowed Charles River to establish itself as a full-service, early-stage contract research organization with integrated in vitro and in vivo capabilities from target discovery through pre-clinical development.
In July 2015, the company announced it would acquire Celsis International for $212 million.
In 2016, the company announced it was set to acquire WIL Research for approximately $585 million in cash and Blue Stream Laboratories.
In August 2017, the business announced it would acquire Brains On-Line.
In January 2018, the company announced it would acquire KWS BioTest for up to £18 million ($24.4 million). In February of the same year, Charles River announced it would acquire MPI Research for approximately $800 million in cash. The transaction was completed on April 3, 2018.
In February 2019, the company announced it would acquire Citoxlab for €448 million in cash (approximately $500 million), including the former acquisitions of the French company, AccelLAB, Atlanbio and Solvo Biotechnology. The transaction was completed on April 29. In December of the same year the business announced it would acquire HemaCare for approximately $380 million in cash.
In August 2020, the company announced it would acquire Cellero for $38 million in cash.
In January 2021, the company announced it would acquire Distributed Bio, Inc., an antibody discovery business.
In February 2021, Charles River announced it would acquire Cognate BioServices, Inc. for $875 million.
In March 2021, Charles River announced the acquisition of Retrogenix for $48 million.
In May 2021, Charles River announced the acquisition of Vigene Biosciences, a gene therapy contract development and manufacturing organization (CDMO), for $292.5 million.
In October 2021, a Japanese subsidiary of Charles River was acquired by Jackson Laboratory for $63M.
In April 2022, the company announced it would acquire Explora BioLabs.
In January 2023, the business announced it would acquire SAMDI Tech, Inc.
स्रोत: विकिपीडिया (अंग्रेज़ी), CC BY-SA 4.0 · विकिपीडिया पर देखें ↗
क्षेत्रHealthcare
उद्योगLife Sciences Tools & Services
कर्मचारी18300
देशUS
10-वर्षीय प्रदर्शन राजस्व, शुद्ध आय, मार्जिन और ईपीएस रुझान
राजस्व$4.02B2016-12-31 → 2025-12-27
EPS$-2.912016-12-31 → 2025-12-27
फ्री कैश फ्लो$518M2016-12-31 → 2025-12-27
शुद्ध मार्जिन-6.0%2016-12-31 → 2025-12-27
मूल्यांकन और अनुपात
मूल्यांकन P/E, P/S, P/B, EV/EBITDA अनुपात — क्या स्टॉक महंगा है या सस्ता?
| मेट्रिक | 5Y रुझान | CRL | 5Y औसत | सहकर्मी माध्यिका | निर्णय |
|---|---|---|---|---|---|
| P/E (TTM) | -60.55Y औसत ≈191.6 | ≈191.6 | · | · | |
| P/S (TTM) | 3.55Y औसत ≈3.2 | ≈3.2 | 4.9 | अल्पमूल्यित | |
| P/B (MRQ) | 4.95Y औसत ≈4.1 | ≈4.1 | 3.6 | उचित मूल्य | |
| EV / EBITDA | 32.85Y औसत ≈16.9 | ≈16.9 | 25.4 | अल्पमूल्यित | |
| मूल्य / FCF (TTM) | 37.45Y औसत ≈28.8 | ≈28.8 | · | · | |
| मूल्य / नकदी प्रवाह (TTM) | 23.85Y औसत ≈17.3 | ≈17.3 | 26.2 | अल्पमूल्यित | |
| EV / Revenue (EV / राजस्व) | 3.55Y औसत ≈3.1 | ≈3.1 | · | · | |
| EV / FCF | 27.15Y औसत ≈28.3 | ≈28.3 | · | · | |
| मूल्य / मूर्त पुस्तक (MRQ) | 5.4 | · | · | · |
सहकर्मी माध्यिका को प्रति मीट्रिक मानकीकृत आधार पर गणना की जाती है और यह हमेशा इस स्टॉक के लिए दिखाए गए TTM/MRQ आधार से मेल नहीं खा सकती है।
लाभप्रदता सकल, परिचालन और शुद्ध मार्जिन; ROE, ROA, ROIC
| मेट्रिक | 5Y रुझान | CRL | 5Y औसत | सहकर्मी माध्यिका | निर्णय |
|---|---|---|---|---|---|
| परिचालन मार्जिन (TTM) | 2.3%5Y औसत ≈10.8% | ≈10.8% | 12.1% | अनुरूप | |
| EBITDA मार्जिन (TTM) | 9.7%5Y औसत ≈19.2% | ≈19.2% | 14.8% | शीर्ष स्तर | |
| Pretax Margin (प्रीटैक्स मार्जिन) | -2.5%5Y औसत ≈8.6% | ≈8.6% | 12.4% | कमजोर | |
| शुद्ध लाभ मार्जिन (TTM) | -6.0%5Y औसत ≈6.3% | ≈6.3% | 10.8% | कमजोर | |
| ROA (TTM) | -3.2%5Y औसत ≈3.4% | ≈3.4% | 2.0% | कमजोर | |
| ROE (TTM) | -7.7%5Y औसत ≈9.0% | ≈9.0% | 3.3% | कमजोर | |
| ROIC | 1.1%5Y औसत ≈10.7% | ≈10.7% | 3.0% | कमजोर |
वित्तीय स्वास्थ्य ऋण, तरलता, शोधन क्षमता — बैलेंस शीट की मजबूती
| मेट्रिक | 5Y रुझान | CRL | 5Y औसत | सहकर्मी माध्यिका | निर्णय |
|---|---|---|---|---|---|
| ऋण / इक्विटी (MRQ) | 0.05Y औसत ≈0.0 | ≈0.0 | 0.1 | कम ऋण | |
| वर्तमान अनुपात (MRQ) | 1.35Y औसत ≈1.4 | ≈1.4 | 1.8 | कम तरलता | |
| Quick Ratio (त्वरित अनुपात) | 0.85Y औसत ≈0.9 | ≈0.9 | 1.2 | कम तरलता |
विकास राजस्व, EPS और शुद्ध आय वृद्धि: YoY, 3Y CAGR, 5Y CAGR
| मेट्रिक | 5Y रुझान | CRL | 5Y औसत | सहकर्मी माध्यिका | निर्णय |
|---|---|---|---|---|---|
| Revenue YoY (राजस्व YoY) | -0.85%5Y औसत ≈6.9% | ≈6.9% | · | · | |
| Revenue CAGR 3Y (राजस्व CAGR 3Y) | 0.33%5Y औसत ≈5.7% | ≈5.7% | · | · | |
| Revenue CAGR 5Y (राजस्व CAGR 5Y) | 6.6% | · | · | · | |
| EPS YoY | -97.8%5Y औसत ≈-17.6% | ≈-17.6% | · | · | |
| Net Income YoY (शुद्ध आय YoY) | -95.3%5Y औसत ≈-16.5% | ≈-16.5% | · | · | |
| EPS CAGR 3Y | -70.3% | · | · | · | |
| Net Income CAGR 3Y (शुद्ध आय CAGR 3Y) | -61.6% | · | · | · |
पूंजी दक्षता एसेट टर्नओवर, इन्वेंटरी टर्नओवर, प्राप्य टर्नओवर
| मेट्रिक | 5Y रुझान | CRL | 5Y औसत | सहकर्मी माध्यिका | निर्णय |
|---|---|---|---|---|---|
| Asset Turnover (परिसंपत्ति टर्नओवर) | 0.55Y औसत ≈0.5 | ≈0.5 | 0.5 | अनुरूप | |
| Receivables Turnover (प्राप्य टर्नओवर) | 5.65Y औसत ≈5.5 | ≈5.5 | 5.6 | अनुरूप | |
| Revenue / Employee (राजस्व / कर्मचारी (रिपोर्ट की गई हेडकाउंट, यफाइनांस)। व्युत्पन्न — संग्रहीत SEC-XBRL अवधारणा नहीं है।) | ≈$219.4K | · | · | · |
मान · ≈ 5Y औसत · उद्योग माध्य · माध्य के सापेक्ष निर्णय
Earnings History EPS वास्तविक बनाम अनुमान, आश्चर्य %, बीट दर, अगली आय तिथि
औसत आश्चर्य
8.9%
अगली रिपोर्ट
नव 03, 2026
| Period | रिपोर्ट | EPS Actual | EPS अनुमान | आश्चर्य |
|---|---|---|---|---|
| 30 जून 2026 | अग 12, 2026 | $3.02 | $2.76 | 9.2% |
| 31 मार्च 2026 | $2.06 | $1.96 | 5.0% | |
| 31 दिसमबर 2025 | $2.39 | $2.37 | 0.98% | |
| 30 सितमबर 2025 | $2.43 | $2.36 | 2.9% | |
| 30 जून 2025 | $3.12 | $2.52 | 23.7% | |
| 31 मार्च 2025 | $2.34 | $2.10 | 11.4% |
पूर्ण मौलिक सभी मेट्रिक्स प्रति वर्ष — आय विवरण, बैलेंस शीट, नकदी प्रवाह
आय विवरण
| मेट्रिक | रुझान | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $4.02B | $4.05B | $4.13B | $3.98B | $3.54B | $2.92B | $2.62B | $2.27B | $1.86B | $1.68B | $1.36B | $1.30B | |
| Cost of Revenue | · | · | · | · | · | · | · | · | $290M | $277M | $264M | $266M | |
| SG&A Expense | $743M | $751M | $748M | $665M | $620M | $529M | $518M | $444M | $371M | $365M | $300M | $269M | |
| Operating Income | $25M | $227M | $617M | $651M | $590M | $433M | $351M | $331M | $288M | $238M | $206M | $178M | |
| Interest Expense | · | · | $137M | $59M | $74M | $86M | $61M | $64M | $30M | $28M | $15M | $12M | |
| Interest Income | $5M | $9M | $5M | $780.0K | $652.0K | $834.0K | $2M | $812.0K | $690.0K | $1M | $1M | $1M | |
| Other Non-op | $-23M | $-17M | $96M | $31M | $-36M | $100M | $12M | $13M | $38M | $12M | $3M | $11M | |
| Pretax Income | $-100M | $93M | $581M | $623M | $481M | $447M | $304M | $282M | $297M | $223M | $195M | $178M | |
| Income Tax | $43M | $68M | $101M | $130M | $82M | $82M | $50M | $54M | $171M | $67M | $43M | $48M | |
| Net Income | $-144M | $22M | $475M | $486M | $391M | $364M | $252M | $226M | $123M | $155M | $149M | $127M | |
| EPS (Basic) | $-2.91 | $0.20 | $9.27 | $9.57 | $7.77 | $7.35 | $5.17 | $4.72 | $2.60 | $3.29 | $3.21 | $2.72 | |
| EPS (Diluted) | $-2.91 | $0.20 | $9.22 | $9.48 | $7.60 | $7.20 | $5.07 | $4.62 | $2.54 | $3.23 | $3.13 | $2.66 | |
| Shares (Basic) | 49,564,000 | 51,380,000 | 51,227,000 | 50,812,000 | 50,293,000 | 49,550,000 | 48,730,000 | 47,947,000 | 47,481,000 | 47,014,000 | 46,496,000 | 46,627,000 | |
| Shares (Diluted) | 49,564,000 | 51,628,000 | 51,451,000 | 51,301,000 | 51,425,000 | 50,611,000 | 49,693,000 | 49,018,000 | 48,564,000 | 47,958,000 | 47,634,000 | 47,558,000 | |
| EBITDA | $428M | $589M | $931M | $955M | $855M | $668M | $549M | $493M | $419M | $364M | $301M | $274M |
बैलेंस शीट
| मेट्रिक | रुझान | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $214M | $195M | $277M | $234M | $241M | $228M | $238M | $195M | $164M | $118M | $118M | $160M | |
| Short-term Investments | · | · | · | · | $1M | $1M | $941.0K | $885.0K | $28M | $4M | $21M | · | |
| Receivables | $709M | $721M | $780M | $752M | $643M | $618M | $514M | $472M | $430M | $364M | $270M | $258M | |
| Inventory | $299M | $279M | $380M | $256M | $199M | $186M | $161M | $128M | $115M | $96M | $94M | $89M | |
| Prepaid Expense | $129M | $106M | $83M | $108M | $97M | $73M | $56M | $49M | $81M | $45M | $47M | $45M | |
| Other Current Assets | · | · | · | · | · | $0 | $300.0K | $300.0K | $0 | $45M | $47M | $73M | |
| Current Assets | $1.45B | $1.40B | $1.61B | $1.44B | $1.27B | $1.20B | $1.02B | $898M | $827M | $657M | $559M | $579M | |
| PP&E (Net) | $1.66B | $1.60B | $1.64B | $1.47B | $1.29B | $1.12B | $1.04B | $933M | $782M | $756M | $678M | $677M | |
| PP&E (Gross) | $3.19B | $3.06B | $2.98B | $2.63B | $2.39B | $2.21B | $2.02B | $1.81B | $1.58B | $1.46B | $1.32B | $1.33B | |
| Accum. Depreciation | $1.54B | $1.45B | $1.34B | $1.16B | $1.10B | $1.09B | $978M | $874M | $801M | $706M | $645M | $655M | |
| Goodwill | $2.76B | $2.85B | $3.10B | $2.85B | $2.71B | $1.81B | $1.54B | $1.25B | $805M | $788M | $439M | $321M | |
| Intangibles | $340M | $723M | $864M | $955M | $1.06B | $788M | $689M | $611M | $370M | $394M | $281M | $281M | |
| Other Non-current Assets | $293M | $278M | $309M | $148M | $152M | $353M | $213M | $144M | $124M | $88M | $72M | $73M | |
| Total Assets | $7.14B | $7.53B | $8.20B | $7.60B | $7.02B | $5.49B | $4.69B | $3.86B | $2.93B | $2.71B | $2.07B | $1.87B | |
| Accounts Payable | $149M | $140M | $169M | $206M | $198M | $122M | $111M | $66M | $78M | $68M | $37M | $34M | |
| Accrued Liabilities | $270M | $232M | $228M | $220M | $229M | $150M | $139M | $107M | $90M | $84M | $89M | $67M | |
| Current Liabilities | $1.12B | $994M | $1.06B | $1.09B | $1.03B | $840M | $710M | $558M | $464M | $430M | $312M | $295M | |
| Capital Leases | $434M | $484M | $419M | $390M | $253M | $156M | $116M | · | · | · | · | · | |
| Deferred Tax | $95M | $107M | $191M | $216M | $240M | $217M | $167M | $144M | $90M | $56M | $48M | $23M | |
| Other Non-current Liabilities | $138M | $195M | $223M | $175M | $243M | $205M | $183M | $179M | $195M | $159M | $89M | $100M | |
| Total Liabilities | $3.92B | $4.02B | $4.54B | $4.58B | $4.43B | $3.35B | $3.03B | $2.52B | $1.87B | $1.86B | $1.30B | $1.17B | |
| Long-term Debt | · | · | · | · | · | · | · | $1.61B | $1.09B | $1.18B | $814M | $717M | |
| Total Debt | $166.0K | $155.0K | $3M | $1M | $101.0K | $47M | $36M | $1.65B | $1.12B | $1.21B | $836M | $754M | |
| Common Stock | $492.0K | $511.0K | $513.0K | $509.0K | $505.0K | $498.0K | $489.0K | $482.0K | $875.0K | $863.0K | $855.0K | $845.0K | |
| Retained Earnings | $1.39B | $1.81B | $1.89B | $1.43B | $981M | $625M | $280M | $42M | $289M | $165M | $11M | $-139M | |
| Treasury Stock | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $55.0K | $1.66B | $1.55B | $1.54B | $1.42B | |
| AOCI | $-172M | $-317M | $-196M | $-262M | $-165M | $-139M | $-178M | $-173M | $-145M | $-254M | $-136M | $-74M | |
| Stockholders' Equity | $3.16B | $3.46B | $3.60B | $2.98B | $2.53B | $2.11B | $1.63B | $1.32B | $1.05B | $837M | $733M | $672M | |
| Liabilities + Equity | $7.14B | $7.53B | $8.20B | $7.60B | $7.02B | $5.49B | $4.69B | $3.86B | $2.93B | $2.71B | $2.07B | $1.87B | |
| Shares Outstanding | 49,217,000 | 51,141,000 | 51,338,000 | 50,944,000 | 50,480,000 | 49,767,000 | 48,936,000 | 48,209,000 | 47,402,000 | 47,363,000 | 46,698,000 | 47,327,000 |
नकदी प्रवाह
| मेट्रिक | रुझान | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $403M | $362M | $314M | $304M | $266M | $235M | $198M | $162M | $131M | $127M | $95M | $96M | |
| Stock-based Comp | $71M | $70M | $72M | $74M | $71M | $56M | $57M | $47M | $44M | $44M | $40M | $31M | |
| Deferred Tax | $-75M | $-67M | $-51M | $-33M | $-20M | $2M | $-21M | $-10M | $28M | $3M | $4M | $9M | |
| Amort. of Intangibles | $179M | $138M | $137M | $147M | $125M | $112M | $90M | $65M | $41M | $42M | $24M | $26M | |
| Restructuring | $100M | $107M | $30M | $8M | $7M | $13M | $14M | $10M | $5M | $18M | $8M | $8M | |
| Other Non-cash | $483M | $348M | $-126M | $-211M | $53M | $-111M | $-5M | $16M | $-8M | $-28M | $-395.0K | · | |
| Operating Cash Flow | $738M | $735M | $684M | $620M | $761M | $547M | $481M | $441M | $318M | $317M | $307M | $252M | |
| CapEx | $219M | $233M | $319M | $325M | $229M | $167M | $141M | $140M | $82M | $55M | $63M | $57M | |
| Investing Cash Flow | $-209M | $-245M | $-563M | $-608M | $-1.44B | $-602M | $-682M | $-955M | $-73M | $-693M | · | · | |
| Debt Issued | $1.23B | $1.08B | $776M | $2.95B | $6.95B | $2.23B | $3.36B | $2.76B | $237M | $1.04B | · | · | |
| Net Debt Issued | $1.23B | $1.08B | $776M | $2.95B | $6.95B | $2.23B | $3.36B | $2.76B | · | · | · | · | |
| Stock Repurchased | $361M | $119M | $24M | $39M | $41M | $24M | $18M | $14M | $107M | $12M | $117M | $122M | |
| Net Stock Activity | $-361M | $-119M | $-24M | $-39M | $-41M | $-24M | $-18M | $-14M | $-107M | $-12M | $-117M | $-122M | |
| Financing Cash Flow | $-537M | $-551M | $-86M | $-42M | $673M | $47M | $232M | $558M | $-208M | $381M | · | · | |
| Net Change in Cash | $10M | $-79M | $43M | $-5M | $13M | $-7M | $43M | $31M | $46M | $-69.0K | $-43M | $4M | |
| Taxes Paid | $120M | $126M | $90M | $76M | $75M | $60M | $54M | $68M | · | · | · | · | |
| Free Cash Flow | $518M | $502M | $365M | $295M | $532M | $380M | $340M | $301M | $236M | $245M | $225M | $195M | |
| Levered FCF | · | · | $252M | $248M | $471M | $309M | $290M | $250M | $223M | $226M | $213M | $186M |
लाभप्रदता
| मेट्रिक | रुझान | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | 0.63% | 5.6% | 14.9% | 16.4% | 16.7% | 14.8% | 13.4% | 14.6% | 15.5% | 14.1% | 15.1% | 13.7% | |
| Net Margin | -3.6% | 0.55% | 11.5% | 12.2% | 11.0% | 12.5% | 9.6% | 10.0% | 6.6% | 9.2% | 10.9% | · | |
| Pretax Margin | -2.5% | 2.3% | 14.1% | 15.7% | 13.6% | 15.3% | 11.6% | 12.4% | 16.0% | 13.3% | 14.3% | 13.7% | |
| EBITDA Margin | 10.7% | 14.5% | 22.6% | 24.0% | 24.2% | 22.8% | 20.9% | 21.8% | 22.5% | 21.6% | 22.1% | 21.1% | |
| ROA | -2.0% | 0.28% | 6.0% | 6.7% | 6.2% | 7.1% | 5.9% | 6.7% | 4.4% | 6.5% | 7.6% | · | |
| ROE | -4.4% | 0.63% | 14.4% | 17.6% | 16.8% | 19.4% | 17.1% | 19.2% | 13.1% | 19.7% | 21.2% | · | |
| ROIC | 1.1% | 1.8% | 14.2% | 17.3% | 19.3% | 16.4% | 17.6% | 9.0% | 5.6% | 8.1% | 10.2% | 9.1% |
तरलता और शोधन क्षमता
| मेट्रिक | रुझान | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 1.3 | 1.4 | 1.5 | 1.3 | 1.2 | 1.4 | 1.4 | 1.6 | 1.8 | 1.5 | 1.8 | 2.0 | |
| Quick Ratio | 0.8 | 0.9 | 1.0 | 0.9 | 0.9 | 1.0 | 1.1 | 1.2 | 1.3 | 1.1 | 1.2 | 1.4 | |
| Debt / Equity | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 1.3 | 1.1 | 1.4 | 1.1 | 1.1 | |
| LT Debt / Equity | · | · | · | · | · | · | · | 1.2 | 1.0 | 1.4 | 1.1 | 1.1 | |
| Interest Coverage | · | · | 4.5 | 11.0 | 8.0 | 5.0 | 5.8 | 5.2 | 9.7 | 8.6 | 13.7 | 14.9 |
दक्षता
| मेट्रिक | रुझान | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.5 | 0.5 | 0.5 | 0.5 | 0.6 | 0.6 | 0.6 | 0.7 | 0.7 | 0.7 | 0.7 | 0.7 | |
| Inventory Turnover | · | · | · | · | · | · | · | · | 2.7 | 2.9 | 2.9 | 3.0 | |
| Receivables Turnover | 5.6 | 5.4 | 5.4 | 5.7 | 5.6 | 5.2 | 5.3 | 5.0 | 4.7 | 5.3 | 5.2 | 5.4 |
प्रति शेयर
| मेट्रिक | रुझान | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $64.30 | $67.69 | $70.06 | $58.42 | $50.21 | $42.49 | $33.40 | $27.33 | $22.05 | $17.67 | $15.70 | $14.20 | |
| Revenue / Share | $81.01 | $78.45 | $80.26 | $77.50 | $68.84 | $57.77 | $52.75 | $46.23 | $38.25 | $35.06 | · | · | |
| Cash Flow / Share | $14.88 | $14.23 | $13.29 | $12.08 | $14.79 | $10.80 | $9.68 | $9.00 | $6.55 | $6.26 | · | · | |
| Cash / Share | $4.34 | $3.81 | $5.39 | $4.59 | $4.78 | $4.59 | $4.86 | $4.05 | $3.46 | $2.48 | $2.53 | $3.38 | |
| EPS (TTM) | $-2.91 | $0.20 | $9.22 | $9.48 | $7.60 | $7.20 | $5.07 | $4.62 | $2.54 | $3.23 | $3.13 | $2.66 |
विकास दरें
| मेट्रिक | रुझान | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY | -0.85% | -1.9% | 3.9% | 12.3% | 21.1% | · | · | · | · | · | · | · | |
| Revenue CAGR 3Y | 0.33% | 4.6% | 12.2% | · | · | · | · | · | · | · | · | · | |
| Revenue CAGR 5Y | 6.6% | · | · | · | · | · | · | · | · | · | · | · | |
| EPS YoY | · | -97.8% | -2.7% | 24.7% | 5.6% | · | · | · | · | · | · | · | |
| EPS CAGR 3Y | · | -70.3% | 8.6% | · | · | · | · | · | · | · | · | · | |
| Net Income YoY | · | -95.3% | -2.4% | 24.4% | 7.3% | · | · | · | · | · | · | · | |
| Net Income CAGR 3Y | · | -61.6% | 9.2% | · | · | · | · | · | · | · | · | · |
मूल्यांकन (TTM)
| मेट्रिक | रुझान | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $4.02B | $4.05B | $4.13B | $3.98B | $3.54B | $2.92B | $2.62B | $2.27B | $1.86B | $1.68B | $1.36B | $1.30B | |
| Net Income TTM | $-144M | $22M | $475M | $486M | $391M | $364M | $252M | $226M | $123M | $155M | $149M | $127M | |
| Market Cap | $10.02B | $9.52B | $12.14B | $11.10B | $18.64B | $12.53B | $7.43B | $5.39B | $5.19B | $3.61B | $3.74B | $3.04B | |
| Enterprise Value | $9.81B | $9.33B | $11.86B | $10.87B | $18.40B | $12.34B | $7.23B | $6.84B | $6.12B | $4.70B | $4.46B | $3.64B | |
| P/E | -70.0 | 930.8 | 25.6 | 23.0 | 48.6 | 35.0 | 30.0 | 24.2 | 43.1 | 23.6 | 25.6 | 24.2 | |
| P/S | 2.5 | 2.4 | 2.9 | 2.8 | 5.3 | 4.3 | 2.8 | 2.4 | 2.8 | 2.1 | 2.7 | 2.3 | |
| P/B | 3.2 | 2.8 | 3.4 | 3.7 | 7.4 | 5.9 | 4.5 | 4.1 | 5.0 | 4.3 | 5.1 | 4.5 | |
| P / Tangible Book | 166.0 | · | · | · | · | · | · | · | · | · | · | · | |
| P / Cash Flow | 13.6 | 13.0 | 17.7 | 17.9 | 24.5 | 22.9 | 15.5 | 12.2 | 16.3 | 12.0 | 13.0 | 12.1 | |
| P / FCF | 19.3 | 19.0 | 33.2 | 37.6 | 35.0 | 33.0 | 21.8 | 17.9 | 22.0 | 14.7 | 16.6 | 15.6 | |
| EV / EBITDA | 22.9 | 15.8 | 12.7 | 11.4 | 21.5 | 18.5 | 13.2 | 13.9 | 14.6 | 12.9 | 14.8 | 13.3 | |
| EV / FCF | 18.9 | 18.6 | 32.5 | 36.9 | 34.6 | 32.5 | 21.2 | 22.7 | 26.0 | 19.2 | 19.8 | 18.6 | |
| EV / Revenue | 2.4 | 2.3 | 2.9 | 2.7 | 5.2 | 4.2 | 2.8 | 3.0 | 3.3 | 2.8 | 3.3 | 2.8 | |
| Earnings Yield | -1.4% | 0.11% | 3.9% | 4.3% | 2.1% | 2.9% | 3.3% | 4.1% | 2.3% | 4.2% | 3.9% | 4.1% |
आय विवरण
| मेट्रिक | रुझान | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $1.00B | $996M | $994M | $1.00B | $1.03B | $984M | $1.00B | $1.01B | $1.03B | $1.01B | $1.01B | $1.03B | $1.03B | $1.10B | $989M | |
| Cost of Revenue | · | · | · | · | · | · | · | $661M | $672M | $667M | · | $665M | $652M | · | · | |
| SG&A Expense | $229M | $159M | $196M | $178M | $192M | $178M | $196M | $199M | $170M | $186M | $197M | $176M | $175M | $200M | $184M | |
| Operating Income | $120M | $120M | $-283M | $134M | $100M | $75M | $-168M | $117M | $152M | $126M | $133M | $152M | $168M | $164M | $151M | |
| Interest Expense | · | · | · | · | · | · | · | · | · | $35M | · | $34M | $34M | · | $11M | |
| Interest Income | $1M | $1M | $1M | $1M | $1M | $1M | $2M | $2M | $3M | $2M | $2M | $1M | $806.0K | $343.0K | $122.0K | |
| Other Non-op | $-37M | $-124M | $12M | $-23M | $154.0K | $-12M | $-23M | $3M | $-2M | $6M | $108M | $-6M | $-3M | $116M | $-17M | |
| Income Tax | $54M | $-15M | $-18M | $32M | $19M | $10M | $-3M | $21M | $25M | $25M | $20M | $25M | $27M | $56M | $25M | |
| Net Income | $-1M | $-15M | $-277M | $54M | $52M | $25M | $-214M | $70M | $94M | $73M | $187M | $87M | $103M | $187M | $96M | |
| EPS (Basic) | $-0.03 | $-0.30 | $-5.58 | $1.11 | $1.06 | $0.50 | $-4.20 | $1.34 | $1.75 | $1.31 | $3.65 | $1.70 | $2.02 | $3.68 | $1.90 | |
| EPS (Diluted) | $-0.03 | $-0.30 | $-5.57 | $1.10 | $1.06 | $0.50 | $-4.17 | $1.33 | $1.74 | $1.30 | $3.64 | $1.69 | $2.01 | $3.66 | $1.88 | |
| Shares (Basic) | 48,021,000 | 48,951,000 | · | 49,213,000 | 49,149,000 | 50,677,000 | · | 51,394,000 | 51,551,000 | 51,437,000 | · | 51,283,000 | 51,097,000 | · | 50,870,000 | |
| Shares (Diluted) | 48,021,000 | 48,951,000 | · | 49,426,000 | 49,316,000 | 50,853,000 | · | 51,583,000 | 51,846,000 | 51,842,000 | · | 51,607,000 | 51,428,000 | · | 51,283,000 | |
| EBITDA | $187M | $187M | · | $219M | $220M | $195M | · | $206M | $238M | $211M | · | $230M | $245M | · | $226M |
बैलेंस शीट
| मेट्रिक | रुझान | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $192M | $192M | $214M | $207M | $183M | $229M | $195M | $210M | $179M | $327M | · | $157M | $202M | · | $194M | |
| Short-term Investments | · | · | · | · | · | · | · | · | · | · | · | · | · | · | $950.0K | |
| Receivables | $712M | $700M | $709M | $734M | $768M | $757M | $721M | $754M | $762M | $787M | · | $799M | $788M | · | $771M | |
| Inventory | $346M | $360M | $299M | $303M | $280M | $290M | $279M | $336M | $349M | $361M | · | $293M | $263M | · | $262M | |
| Prepaid Expense | $179M | $135M | $129M | $166M | $130M | $100M | $106M | $102M | $111M | $99M | · | $93M | $92M | · | $97M | |
| Current Assets | $1.53B | $1.49B | $1.45B | $1.53B | $1.47B | $1.51B | $1.40B | $1.49B | $1.50B | $1.67B | · | $1.44B | $1.45B | · | $1.42B | |
| PP&E (Net) | $1.49B | $1.51B | $1.66B | $1.59B | $1.61B | $1.59B | $1.60B | · | · | · | · | · | · | · | · | |
| PP&E (Gross) | $2.96B | $2.94B | $3.19B | $3.09B | $3.10B | $3.05B | $3.06B | · | · | · | · | · | · | · | · | |
| Accum. Depreciation | $1.46B | $1.43B | $1.54B | $1.50B | $1.50B | $1.46B | $1.45B | · | · | · | · | · | · | · | · | |
| Goodwill | $3.08B | $3.04B | $2.76B | $2.92B | $2.94B | $2.87B | $2.85B | $3.12B | $3.08B | $3.07B | · | $2.88B | $2.90B | · | $2.78B | |
| Intangibles | $253M | $249M | $340M | $571M | $602M | $656M | $723M | $778M | $800M | $828M | · | $886M | $958M | · | $968M | |
| Other Non-current Assets | $588M | $826M | $293M | $291M | $296M | $294M | $278M | $307M | $301M | $303M | · | $155M | $154M | · | $430M | |
| Total Assets | $7.53B | $7.73B | $7.14B | $7.51B | $7.56B | $7.58B | $7.53B | $8.00B | $7.95B | $8.15B | · | $7.61B | $7.70B | · | $7.38B | |
| Accounts Payable | $141M | $134M | $149M | $170M | $146M | $149M | $140M | $136M | $133M | $130M | · | $136M | $120M | · | $182M | |
| Accrued Liabilities | $380M | $372M | $270M | $229M | $232M | $242M | $232M | $208M | $192M | $191M | · | $198M | $221M | · | $197M | |
| Current Liabilities | $1.13B | $1.09B | $1.12B | $1.12B | $1.08B | $1.05B | $994M | $1.01B | $948M | $955M | · | $994M | $981M | · | $1.01B | |
| Capital Leases | $408M | $393M | $434M | $443M | $454M | $475M | $484M | $433M | $429M | $418M | · | $390M | $418M | · | $369M | |
| Deferred Tax | $79M | $81M | $95M | $123M | $109M | $107M | $107M | $168M | $165M | $180M | · | $185M | $212M | · | $196M | |
| Other Non-current Liabilities | $403M | $511M | $138M | $189M | $185M | $196M | $195M | $237M | $225M | $235M | · | $173M | $187M | · | $195M | |
| Total Liabilities | $4.64B | $4.74B | $3.92B | $4.06B | $4.16B | $4.34B | $4.02B | $4.18B | $4.18B | $4.45B | · | $4.26B | $4.54B | · | $4.71B | |
| Total Debt | $5M | $7M | · | $54.0K | $98.0K | $121.0K | · | $157.0K | $435.0K | $459.0K | · | $797.0K | · | · | $0 | |
| Common Stock | $496.0K | $493.0K | $492.0K | $514.0K | $513.0K | $512.0K | $511.0K | $517.0K | $517.0K | $515.0K | · | $514.0K | $512.0K | · | $510.0K | |
| Retained Earnings | $1.37B | $1.37B | $1.39B | $1.94B | $1.89B | $1.84B | $1.81B | $2.12B | $2.05B | $1.96B | · | $1.72B | $1.54B | · | $1.28B | |
| Treasury Stock | $323M | $210M | $0 | $363M | $363M | $357M | $0 | $120M | $18M | $9M | · | $24M | $19M | · | $38M | |
| AOCI | $-196M | $-191M | $-172M | $-192M | $-166M | $-265M | $-317M | $-193M | $-270M | $-250M | · | $-268M | $-239M | · | $-396M | |
| Stockholders' Equity | $2.84B | $2.94B | $3.16B | $3.41B | $3.35B | $3.19B | $3.46B | $3.78B | $3.72B | $3.64B | · | $3.31B | $3.11B | · | $2.63B | |
| Liabilities + Equity | $7.53B | $7.73B | $7.14B | $7.51B | $7.56B | $7.58B | $7.53B | $8.00B | $7.95B | $8.15B | · | $7.61B | $7.70B | · | $7.38B | |
| Shares Outstanding | 47,728,000 | 48,167,000 | 49,217,000 | 49,215,000 | 49,209,000 | 49,115,000 | 51,141,000 | 51,134,000 | 51,613,000 | 51,510,000 | · | 51,296,000 | 51,182,000 | 50,944,000 | 50,877,000 |
नकदी प्रवाह
| मेट्रिक | रुझान | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $67M | $67M | $78M | $85M | $120M | $120M | $102M | $88M | $86M | $85M | $81M | $79M | $77M | $78M | $75M | |
| Stock-based Comp | $20M | $22M | $18M | $23M | $17M | $13M | $17M | $19M | $17M | $17M | $20M | $23M | $13M | $22M | $22M | |
| Amort. of Intangibles | $15M | $15M | $21M | $27M | $65M | $65M | $41M | $32M | $32M | $33M | $34M | $34M | $35M | $35M | $36M | |
| Restructuring | $23M | $32M | $26M | $17M | $32M | $24M | $41M | $31M | $18M | $17M | $8M | $15M | $3M | $4M | $1M | |
| Other Non-cash | · | $-34M | · | · | · | $13M | · | · | · | $-45M | · | · | $-84M | · | · | |
| Operating Cash Flow | $180M | $41M | $148M | $214M | $205M | $172M | $159M | $252M | $194M | $130M | $221M | $205M | $109M | $235M | $133M | |
| CapEx | $31M | $56M | $89M | $36M | $35M | $59M | $76M | $39M | $39M | $79M | $78M | $66M | $107M | $89M | $72M | |
| Investing Cash Flow | $28M | $-408M | $-93M | $-34M | $-37M | $-45M | $-76M | $-21M | $-62M | $-86M | $-238M | $-80M | $-169M | $44M | $-92M | |
| Debt Issued | $353M | $912M | $157M | $107M | $547M | $416M | $105M | $236M | $440M | $301M | $443M | $51M | $192M | $154M | $618M | |
| Net Debt Issued | · | $912M | · | · | · | $416M | · | · | · | $301M | · | · | $192M | · | · | |
| Stock Repurchased | $116M | $208M | $96.0K | $93.0K | $7M | $353M | $124.0K | $101M | $9M | $9M | $139.0K | $38.0K | $19M | $159.0K | $24.0K | |
| Net Stock Activity | · | $-208M | · | · | · | $-353M | · | · | · | $-9M | · | · | $-19M | · | · | |
| Financing Cash Flow | $-165M | $348M | $-52M | $-153M | $-227M | $-105M | $-76M | $-208M | $-286M | $18M | $124M | $-163M | $25M | $-249M | $-52M | |
| Net Change in Cash | $42M | $-18M | $7M | $24M | $-47M | $26M | $-6M | $31M | $-158M | $54M | $119M | $-43M | $-32M | $45M | $-11M | |
| Taxes Paid | $16M | $2M | $27M | $19M | $57M | $17M | $31M | $23M | $53M | $19M | $15M | $14M | $14M | · | · | |
| Free Cash Flow | · | $-15M | · | · | · | $112M | · | · | · | $51M | · | · | $3M | · | · |
लाभप्रदता
| मेट्रिक | रुझान | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | 11.9% | 12.0% | · | 13.3% | 9.7% | 7.6% | · | 11.6% | 14.8% | 12.4% | · | 14.8% | 16.3% | · | 15.3% | |
| Net Margin | -0.15% | -1.5% | · | 5.4% | 5.1% | 2.6% | · | 6.9% | 9.2% | 7.2% | · | 8.5% | 10.0% | · | 9.8% | |
| EBITDA Margin | 18.6% | 18.8% | · | 21.8% | 21.3% | 19.8% | · | 20.4% | 23.2% | 20.9% | · | 22.4% | 23.8% | · | 22.8% | |
| ROA | -0.02% | -0.19% | · | 0.70% | 0.67% | 0.32% | · | 0.89% | 1.2% | 0.92% | · | 1.2% | · | · | 1.3% | |
| ROE | -0.05% | -0.48% | · | 1.5% | 1.5% | 0.75% | · | 2.0% | 2.7% | 2.2% | · | 2.9% | · | · | 3.8% |
तरलता और शोधन क्षमता
| मेट्रिक | रुझान | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 1.3 | 1.4 | · | 1.4 | 1.4 | 1.4 | · | 1.5 | 1.6 | 1.7 | · | 1.5 | · | · | 1.4 | |
| Quick Ratio | 0.8 | 0.8 | · | 0.8 | 0.9 | 0.9 | · | 1.0 | 1.0 | 1.2 | · | 1.0 | · | · | 1.0 | |
| Debt / Equity | 0.0 | 0.0 | · | 0.0 | 0.0 | 0.0 | · | 0.0 | 0.0 | 0.0 | · | 0.0 | · | · | 0.0 | |
| Interest Coverage | · | · | · | · | · | · | · | · | · | 3.6 | · | 4.5 | 4.9 | · | 13.3 |
दक्षता
| मेट्रिक | रुझान | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.1 | 0.1 | · | 0.1 | 0.1 | 0.1 | · | 0.1 | 0.1 | 0.1 | · | 0.1 | · | · | 0.1 | |
| Inventory Turnover | · | · | · | · | · | · | · | 2.1 | 2.1 | 2.1 | · | · | · | · | · | |
| Receivables Turnover | 1.4 | 1.4 | · | 1.4 | 1.3 | 1.3 | · | 1.3 | 1.3 | 1.3 | · | 1.3 | · | · | 1.4 |
प्रति शेयर
| मेट्रिक | रुझान | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $59.50 | $61.05 | · | $69.20 | $68.14 | $65.04 | · | $73.97 | $72.13 | $70.67 | · | $64.45 | · | · | $51.63 | |
| Revenue / Share | $20.91 | $20.34 | · | $20.33 | $20.93 | $19.35 | · | $19.58 | $19.79 | $19.51 | · | $19.89 | $20.02 | · | $19.29 | |
| Cash Flow / Share | · | $0.84 | · | · | · | $3.38 | · | · | · | $2.51 | · | · | $2.13 | · | · | |
| Cash / Share | $4.02 | $3.98 | · | $4.21 | $3.72 | $4.67 | · | $4.11 | $3.47 | $6.35 | · | $3.06 | · | · | $3.81 | |
| EPS (TTM) | $-4.80 | $-3.71 | · | $-1.51 | $-1.28 | $-0.60 | · | $8.01 | $8.37 | $8.52 | · | $9.25 | $9.68 | · | $8.49 |
मूल्यांकन (TTM)
| मेट्रिक | रुझान | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $4.00B | $4.03B | · | $4.02B | $4.03B | $4.02B | · | $4.06B | $4.08B | $4.11B | · | $4.22B | $4.09B | · | $3.78B | |
| Net Income TTM | $-238M | $-185M | · | $-82M | $-67M | $-25M | · | $424M | $442M | $444M | · | $475M | $496M | · | $436M | |
| Market Cap | $10.30B | $7.67B | · | $7.31B | $7.38B | $7.64B | · | $10.14B | $10.66B | $13.96B | · | $10.05B | · | · | $9.54B | |
| Enterprise Value | $10.11B | $7.48B | · | $7.10B | $7.20B | $7.41B | · | $9.93B | $10.48B | $13.63B | · | $9.90B | · | · | $9.35B | |
| P/E | -44.9 | -42.9 | · | -98.4 | -117.2 | -259.2 | · | 24.8 | 24.7 | 31.8 | · | 21.2 | 20.8 | · | 22.1 | |
| P/S | 2.6 | 1.9 | · | 1.8 | 1.8 | 1.9 | · | 2.5 | 2.6 | 3.4 | · | 2.4 | 2.5 | · | 2.5 | |
| P/B | 3.6 | 2.6 | · | 2.1 | 2.2 | 2.4 | · | 2.7 | 2.9 | 3.8 | · | 3.0 | · | · | 3.6 | |
| P / Cash Flow | · | 186.6 | · | · | · | 44.5 | · | · | · | 107.5 | · | · | · | · | · | |
| EV / Revenue | 2.5 | 1.9 | · | 1.8 | 1.8 | 1.8 | · | 2.4 | 2.6 | 3.3 | · | 2.3 | 2.5 | · | 2.5 | |
| Earnings Yield | -2.2% | -2.3% | · | -1.0% | -0.85% | -0.39% | · | 4.0% | 4.0% | 3.1% | · | 4.7% | 4.8% | · | 4.5% |
सबसे हाल की अवधि बाईं ओर · शून्य मान इस प्रकार दिखाए गए हैं ·
वित्तीय विवरण आय विवरण, बैलेंस शीट, नकदी प्रवाह — वार्षिक, पिछले 5 वर्ष
| मेट्रिक | 2025-12-27 | 2024-12-28 | 2023-12-30 | 2022-12-31 | 2021-12-25 |
|---|---|---|---|---|---|
| राजस्व | $4.02B | $4.05B | $4.13B | $3.98B | $3.54B |
| परिचालन मार्जिन % | 0.63% | 5.6% | 14.9% | 16.4% | 16.7% |
| शुद्ध आय | $-144M | $22M | $475M | $486M | $391M |
| तनुकरणित EPS | $-2.91 | $0.20 | $9.22 | $9.48 | $7.60 |
| मेट्रिक | 2025-12-27 | 2024-12-28 | 2023-12-30 | 2022-12-31 | 2021-12-25 |
|---|---|---|---|---|---|
| ऋण / इक्विटी | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
| वर्तमान अनुपात | 1.3 | 1.4 | 1.5 | 1.3 | 1.2 |
| त्वरित अनुपात | 0.8 | 0.9 | 1.0 | 0.9 | 0.9 |
| मेट्रिक | 2025-12-27 | 2024-12-28 | 2023-12-30 | 2022-12-31 | 2021-12-25 |
|---|---|---|---|---|---|
| फ्री कैश फ्लो | $518M | $502M | $365M | $295M | $532M |
संस्थागत मालिक (13F) 607 फाइलर्स · $13.6B कुल · तिथि अनुसार 30 सितमबर 2026
संस्थान जो अपनी तिमाही SEC फॉर्म 13F में इस स्टॉक को होल्ड करने की रिपोर्ट करते हैं। केवल लॉन्ग पोजीशन; एक ही फाइलर अलग-अलग ऑप्शन लेग्स के लिए दो बार दिखाई दे सकता है। बड़े ऑफसेटिंग पुट/कॉल लेग्स आमतौर पर मार्केट-मेकिंग या हेज्ड इन्वेंट्री को दर्शाते हैं, न कि दिशात्मक विश्वास को।
धारक
607
धारित मूल्य
$13.6B
नई स्थितियाँ
74
बाहर निकली पोजीशन
62
संस्थागत गतिविधि — Q2 2026 बनाम पिछली तिमाही
| नई स्थितियाँ | बाहर निकली पोजीशन | बढ़ाया | घटा हुआ | शुद्ध शेयर परिवर्तन |
|---|---|---|---|---|
| 74 (-17 पिछली तिमाही की तुलना में) | 62 (-19 पिछली तिमाही की तुलना में) | 193 (0 पिछली तिमाही की तुलना में) | 204 (+13 पिछली तिमाही की तुलना में) | +2.8M |
Q1 2026 की तुलना में। SEC फॉर्म 13F फाइलिंग तिमाही के अंत के 45 दिनों के भीतर देय होती है, साथ ही देर से फाइल करने वालों के लिए एक छोटा बफर भी होता है — उस विंडो के भीतर आने वाली तिमाहियों को सबसे हालिया पूरी तरह से रिपोर्ट की गई जोड़ी के पक्ष में छोड़ दिया जाता है।
| संस्था | मूल्य | शेयर | % ट्रैक किए गए 13F का | प्रकार |
|---|---|---|---|---|
| VANGUARD GROUP INC | $1174373670 | 5887175 | 8.66% | शेयर |
| FMR LLC | $961533236 | 4239752 | 7.09% | शेयर |
| BlackRock, Inc. | $861475349 | 3798560 | 6.35% | शेयर |
| VANGUARD CAPITAL MANAGEMENT LLC | $714227026 | 3149288 | 5.26% | शेयर |
| Invesco Ltd. | $676919391 | 2984785 | 4.99% | शेयर |
| HARRIS ASSOCIATES L P | $508269048 | 2241144 | 3.75% | शेयर |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $501427927 | 2210979 | 3.70% | शेयर |
| Allspring Global Investments Holdings, LLC | $436473035 | 1905247 | 3.22% | शेयर |
| STATE STREET CORP | $422800968 | 1864284 | 3.12% | शेयर |
| DIMENSIONAL FUND ADVISORS LP | $373848597 | 1648450 | 2.76% | शेयर |
| ARIEL INVESTMENTS, LLC | $341587697 | 1506185 | 2.52% | शेयर |
| GEODE CAPITAL MANAGEMENT, LLC | $295598099 | 1305738 | 2.18% | शेयर |
| WELLINGTON MANAGEMENT GROUP LLP | $292210525 | 1288463 | 2.15% | शेयर |
| CITADEL ADVISORS LLC | $270696771 | 1193601 | 2.00% | शेयर |
| BANK OF AMERICA CORP /DE/ | $265930779 | 1172586 | 1.96% | शेयर |
| EARNEST PARTNERS LLC | $254007295 | 1120011 | 1.87% | शेयर |
| AMERIPRISE FINANCIAL INC | $199834979 | 881189 | 1.47% | शेयर |
| NEUBERGER BERMAN GROUP LLC | $195633630 | 862704 | 1.44% | शेयर |
| SEI INVESTMENTS CO | $184499540 | 813530 | 1.36% | शेयर |
| MORGAN STANLEY | $181542851 | 800487 | 1.34% | शेयर |
| Clearbridge Investments, LLC | $177185527 | 781276 | 1.31% | शेयर |
| COOKE & BIELER LP | $171369328 | 755630 | 1.26% | शेयर |
| MASSACHUSETTS FINANCIAL SERVICES CO /MA/ | $157642604 | 682173 | 1.16% | शेयर |
| VICTORY CAPITAL MANAGEMENT INC | $150762735 | 664768 | 1.11% | शेयर |
| UBS Group AG | $146675752 | 646747 | 1.08% | शेयर |
| GOLDMAN SACHS GROUP INC | $145100822 | 639803 | 1.07% | शेयर |
| MILLENNIUM MANAGEMENT LLC | $110324717 | 486462 | 0.81% | शेयर |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | $106061291 | 467663 | 0.78% | शेयर |
| BANK OF MONTREAL /CAN/ | $104270783 | 459768 | 0.77% | शेयर |
| NORTHERN TRUST CORP | $101169205 | 446092 | 0.75% | शेयर |
| Gotham Asset Management, LLC | $98233181 | 433146 | 0.72% | शेयर |
| Amundi | $93528650 | 412402 | 0.69% | शेयर |
| NORGES BANK | $83921372 | 370040 | 0.62% | शेयर |
| MARSHALL WACE, LLP | $77787835 | 342995 | 0.57% | शेयर |
| Iron Triangle Partners LP | $75748141 | 379728 | 0.56% | शेयर |
| CITIGROUP INC | $71714853 | 316217 | 0.53% | शेयर |
| BNP PARIBAS FINANCIAL MARKETS | $69108583 | 304725 | 0.51% | शेयर |
| Bank of New York Mellon Corp | $69054385 | 304486 | 0.51% | शेयर |
| Boston Trust Walden Corp | $65523486 | 288917 | 0.48% | शेयर |
| JPMORGAN CHASE & CO | $65085033 | 286317 | 0.48% | शेयर |
| ALLIANCEBERNSTEIN L.P. | $64615913 | 374585 | 0.48% | शेयर |
| SNYDER CAPITAL MANAGEMENT L P | $63899443 | 281756 | 0.47% | शेयर |
| ARROWSTREET CAPITAL, LIMITED PARTNERSHIP | $63174169 | 278558 | 0.47% | शेयर |
| DEUTSCHE BANK AG\ | $62723084 | 276569 | 0.46% | शेयर |
| VANGUARD FIDUCIARY TRUST CO | $61384115 | 270665 | 0.45% | शेयर |
| PRIMECAP MANAGEMENT CO/CA/ | $60523448 | 266870 | 0.45% | शेयर |
| RAYMOND JAMES FINANCIAL INC | $58234910 | 256779 | 0.43% | शेयर |
| Meridiem Capital Partners LP | $56012367 | 246979 | 0.41% | शेयर |
| Alyeska Investment Group, L.P. | $53295650 | 235000 | 0.39% | शेयर |
| LOOMIS SAYLES & CO L P | $50725593 | 223668 | 0.37% | शेयर |
कार्यकर्ता और 5%+ मालिक 6 होल्डिंग्स
जिन निवेशकों ने SEC शेड्यूल 13D दाखिल किया है — जारीकर्ता को प्रभावित करने के इरादे से 5% से अधिक लाभकारी स्वामित्व (कार्यकर्ता दांव, बोर्ड अभियान, M&A)। प्रत्येक पंक्ति उस फाइलर की स्थिति की सबसे हालिया ज्ञात स्थिति दिखाती है।
| फाइलर | दाखिल किया | दांव | स्थिति | उद्देश्य | फाइलिंग |
|---|---|---|---|---|---|
| JANA PARTNERS LLC ×4 फाइलिंग | 4 अगस्त 2011 | · | प्रारंभिक फाइलिंग | · | SEC |
| Relational Investors, LLC, Relational Investors Mid-Cap Fund I, L.P., Relational Investors Mid-Cap Fund II, L.P., Ralph V. Whitworth, David H. Batchelder, California State Teachers’ Retirement System ×3 फाइलिंग | 9 फ़रवरी 2011 | · | प्रारंभिक फाइलिंग | · | SEC |
| Neuberger Berman Group LLC, Neuberger Berman LLC, Neuberger Berman Management ×3 फाइलिंग | 7 दिसमबर 2010 | · | प्रारंभिक फाइलिंग | · | SEC |
| अघोषित रिपोर्टिंग व्यक्ति | 16 जून 2010 | · | प्रारंभिक फाइलिंग | · | SEC |
| अघोषित रिपोर्टिंग व्यक्ति | 7 जून 2010 | · | प्रारंभिक फाइलिंग | निष्क्रिय निवेश | SEC |
| Charles River Laboratories International, Inc. IRS No. 061397316 | 5 मई 2010 | · | प्रारंभिक फाइलिंग | बोर्ड अभियान | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
कंपनी के अंदरूनी सूत्र 57 इनसाइडर्स · 23 अधिकारी · 29 निदेशक
| अंदरूनी | भूमिका | अंतिम गतिविधि | शेयरों का स्वामित्व | खरीद 12m | बिक्री 12m | नेट 12m |
|---|---|---|---|---|---|---|
| Birgit Girshick | Chief Executive Officer | 19 अगस्त 2026 G | 35485 | 0 | 1 | $-1819350 |
| Glenn Coleman | EVP & Chief Financial Officer | 30 सितमबर 2026 P | 27762 | 1 | 0 | $2974 |
| Flavia Pease | Corporate Executive VP & CFO | 31 मई 2025 F | 17297 | 0 | 0 | $0 |
| David Ross Smith | Corporate Executive VP & CFO | 3 मार्च 2022 M | 25819 | 0 | 0 | $0 |
| Davide Molho | President & COO | 24 जुलाई 2018 M | 17155 | 0 | 0 | $0 |
| Shannon M Parisotto | CEVP, Disc & Safety Assessment | 19 अगस्त 2026 M | 4807 | 0 | 3 | $-2965466 |
| Mark Mintz | EVP, Chief Information Officer | 31 मई 2026 F | 9546 | 0 | 0 | $0 |
| William D Barbo | Corporate Executive VP & CCO | 7 नवमबर 2024 G | 23337 | 0 | 0 | $0 |
| John W Kuo | CEVP General Counsel & CCO | 1 जून 2020 A | 3171 | 0 | 0 | $0 |
| David P Johst | Corporate Executive VP | 29 मई 2020 A | 224478 | 0 | 0 | $0 |
| John J Crowley | SVP, Chief Accounting Officer | 1 अक्टूबर 2016 F | 5599 | 0 | 0 | $0 |
| Nancy Gillett | Corporate Executive VP | 2 मार्च 2016 S | 11034 | 0 | 0 | $0 |
| Jorg Geller | Corporate Executive VP | 25 फ़रवरी 2015 M | 14094 | 0 | 0 | $0 |
| RENAUD REAL H | Corp. Executive VP | 11 अगस्त 2010 F | 74390 | 0 | 0 | $0 |
| Christopher Berthoux | Executive Vice President | 26 फ़रवरी 2010 A | 31897 | 0 | 0 | $0 |
| Joanne P Acford | Corp. Sr VP, GC and Corp. Sec | 11 अगस्त 2007 F | 37109 | 0 | 0 | $0 |
| David J Elliott | Officer | 29 जून 2007 M | 11750 | 0 | 0 | $0 |
| Cheri L Walker | Corporate Senior VP | 1 मई 2007 A | 6262 | 0 | 0 | $0 |
| Stephanie B Wells | Senior Vice President | 2 अप्रैल 2007 A | 11500 | 0 | 0 | $0 |
| Nicholas Ventresca | Senior Vice President | 2 अप्रैल 2007 F | 12713 | 0 | 0 | $0 |
| John C Ho | Senior Vice President | 23 फ़रवरी 2007 A | 12710 | 0 | 0 | $0 |
| Brian Bathgate | Corporate Vice President | 27 फ़रवरी 2006 S | 16134 | 0 | 0 | $0 |
| Alastair Stuart Mcewan | Corporate VP | 23 दिसमबर 2004 M | 8000 | 0 | 0 | $0 |
| James C Foster | निदेशक | 25 अगस्त 2026 M | 31596 | 0 | 3 | $-34844875 |
| Nancy C Andrews | निदेशक | 18 अगस्त 2026 M | 1438 | 0 | 1 | $-163443 |
| Steven Barg | निदेशक | 2 जून 2026 A | 3287 | 0 | 0 | $0 |
| Reshema Kemps-Polanco | निदेशक | 8 मई 2026 A | 4563 | 0 | 0 | $0 |
| George Llado | निदेशक | 8 मई 2026 A | 6702 | 0 | 0 | $0 |
| Abraham Ceesay | निदेशक | 8 मई 2026 A | 2384 | 0 | 0 | $0 |
| Mark J Enyedy | निदेशक | 8 मई 2026 A | 2384 | 0 | 0 | $0 |
| Paul W Graves | निदेशक | 8 मई 2026 A | 2384 | 0 | 0 | $0 |
| Craig B. Thompson | निदेशक | 8 मई 2026 A | 3851 | 0 | 0 | $0 |
| Martin Mackay | निदेशक | 8 मई 2026 A | 17137 | 0 | 0 | $0 |
| Virginia M Wilson | निदेशक | 8 मई 2026 A | 6349 | 0 | 0 | $0 |
| George Massaro | निदेशक | 15 मई 2025 S | 5575 | 0 | 0 | $0 |
| Richard F Wallman | निदेशक | 7 नवमबर 2024 S | 0 | 0 | 0 | $0 |
| Deborah Turner Kochevar | निदेशक | 13 मई 2024 A | 7894 | 0 | 0 | $0 |
| Robert J Bertolini | निदेशक | 13 मई 2024 A | 32802 | 0 | 0 | $0 |
| Richard C Reese | निदेशक | 15 मई 2023 A | 65541 | 0 | 0 | $0 |
| George M Milne JR | निदेशक | 7 मई 2021 A | 29079 | 0 | 0 | $0 |
| Stephen D Chubb | निदेशक | 23 फ़रवरी 2021 M | 40529 | 0 | 0 | $0 |
| Jean-Paul Mangeolle | निदेशक | 22 मई 2019 A | 3886 | 0 | 0 | $0 |
| William Waltrip | निदेशक | 5 दिसमबर 2012 S | 21830 | 0 | 0 | $0 |
| Samuel O Thier MD | निदेशक | 9 मई 2012 A | 18230 | 0 | 0 | $0 |
| Douglas E Rogers | निदेशक | 7 मई 2010 A | 12859 | 0 | 0 | $0 |
| Nancy T Chang | निदेशक | 7 मई 2010 A | 31010 | 0 | 0 | $0 |
| Linda Mcgoldrick | निदेशक | 13 फ़रवरी 2006 A | · | 0 | 0 | $0 |
| Walter S Nimmo | निदेशक | 25 फ़रवरी 2005 S | 149447 | 0 | 0 | $0 |
| John Urquhart | निदेशक | 17 फ़रवरी 2005 A | 11738 | 0 | 0 | $0 |
| Louise S Mccrary | निदेशक | 17 फ़रवरी 2005 A | · | 0 | 0 | $0 |
| Robert Cawthorn | निदेशक | 2 जून 2004 G | 278600 | 0 | 0 | $0 |
| Joseph W Laplume | · | 10 अगस्त 2026 G | 31041 | 1 | 1 | $-61124 |
| Victoria L Creamer | · | 6 अगस्त 2026 M | 30051 | 0 | 1 | $-1083030 |
| Michael Gunnar Knell | · | 6 अगस्त 2026 M | 11852 | 0 | 9 | $-1730250 |
| Thomas F Ackerman | · | 29 फ़रवरी 2016 F | 111346 | 0 | 0 | $0 |
| Dennis R Shaughnessy | · | 29 नवमबर 2004 G | 35511 | 0 | 0 | $0 |
| Michael F Ankcorn | · | 4 नवमबर 2004 S | 0 | 0 | 0 | $0 |
SEC फॉर्म 3/4/5 फाइलिंग से अंदरूनी सूत्र; नेट = केवल ओपन-मार्केट P/S
ईटीएफ स्वामित्व 106 ETFs द्वारा धारित
वजन केवल प्रत्यक्ष इक्विटी होल्डिंग्स (N-PORT) को दर्शाता है; लीवरेज्ड या डेरिवेटिव-आधारित फंड में अतिरिक्त स्वैप एक्सपोजर हो सकता है जो नहीं दिखाया गया है।
| फंड | भार | इकाइयाँ | तिथि अनुसार | स्रोत |
|---|---|---|---|---|
| EPSB · Harbor ETF Trust | 2.15% | 443 NS | 31 जुलाई 2026 | N-PORT |
| RSPH · Invesco Exchange-Traded Fund Trust | 1.73% | 51248 SH | 1 अक्टूबर 2026 | दैनिक |
| HTEC · EXCHANGE TRADED CONCEPTS TRUST | 1.71% | 5092 NS | 31 जुलाई 2026 | N-PORT |
| EPSV · Harbor ETF Trust | 1.59% | 415 NS | 31 जुलाई 2026 | N-PORT |
| EPMV · Harbor ETF Trust | 1.44% | 291 NS | 31 जुलाई 2026 | N-PORT |
| ALTL · Pacer Funds Trust | 1.09% | 4303 NS | 31 जुलाई 2026 | N-PORT |
| IBB · iShares Trust | 0.96% | 363741 SH | 11 सितमबर 2026 | दैनिक |
| LSEQ · Harbor ETF Trust | 0.93% | 614 NS | 31 जुलाई 2026 | N-PORT |
| HIBL · Direxion Shares ETF Trust | 0.74% | 2375 NS | 31 जुलाई 2026 | N-PORT |
| SPHB · Invesco Exchange-Traded Fund Trust … | 0.69% | 22191 SH | 1 अक्टूबर 2026 | दैनिक |
| JDOC · J.P. Morgan Exchange-Traded Fund Tr… | 0.66% | 259 NS | 31 जुलाई 2026 | N-PORT |
| PALC · Pacer Funds Trust | 0.61% | 5509 NS | 31 जुलाई 2026 | N-PORT |
| FNY · First Trust Exchange-Traded AlphaDE… | 0.49% | 12141 NS | 31 जुलाई 2026 | N-PORT |
| IQSM · New York Life Investments ETF Trust | 0.45% | 6439 NS | 31 जुलाई 2026 | N-PORT |
| PKW · Invesco Exchange-Traded Fund Trust | 0.44% | 24918 SH | 1 अक्टूबर 2026 | दैनिक |
| FFSM · FIDELITY COVINGTON TRUST | 0.40% | 25814 NS | 31 जुलाई 2026 | N-PORT |
| DFAT · Dimensional ETF Trust | 0.34% | 209615 NS | 31 जुलाई 2026 | N-PORT |
| BKMC · BNY Mellon ETF Trust | 0.28% | 7783 NS | 31 जुलाई 2026 | N-PORT |
| ESML · iShares Trust | 0.24% | 25082 SH | 11 सितमबर 2026 | दैनिक |
| BBMC · J.P. Morgan Exchange-Traded Fund Tr… | 0.24% | 20898 NS | 31 जुलाई 2026 | N-PORT |
| FSMD · FIDELITY COVINGTON TRUST | 0.24% | 25378 NS | 31 जुलाई 2026 | N-PORT |
| FNX · First Trust Exchange-Traded AlphaDE… | 0.23% | 13626 NS | 31 जुलाई 2026 | N-PORT |
| VBR · VANGUARD INDEX FUNDS | 0.23% | 701498 SH | 19 अगस्त 2026 | दैनिक |
| DFAS · Dimensional ETF Trust | 0.22% | 147648 NS | 31 जुलाई 2026 | N-PORT |
| RSP · Invesco Exchange-Traded Fund Trust | 0.22% | 702813 SH | 1 अक्टूबर 2026 | दैनिक |
| IYH · iShares Trust | 0.22% | 28670 SH | 11 सितमबर 2026 | दैनिक |
| SMMD · iShares Trust | 0.19% | 26152 SH | 11 सितमबर 2026 | दैनिक |
| IXJ · iShares Trust | 0.17% | 25598 SH | 11 सितमबर 2026 | दैनिक |
| FHLC · FIDELITY COVINGTON TRUST | 0.17% | 23486 NS | 31 जुलाई 2026 | N-PORT |
| VHT · VANGUARD WORLD FUND | 0.16% | 148331 SH | 19 अगस्त 2026 | दैनिक |
| REVS · Columbia ETF Trust I | 0.15% | 2111 NS | 31 जुलाई 2026 | N-PORT |
| FAD · First Trust Exchange-Traded AlphaDE… | 0.15% | 3646 NS | 31 जुलाई 2026 | N-PORT |
| WSML · iShares Trust | 0.14% | 6080 SH | 11 सितमबर 2026 | दैनिक |
| IWS · iShares Trust | 0.13% | 73404 SH | 11 सितमबर 2026 | दैनिक |
| VB · VANGUARD INDEX FUNDS | 0.13% | 1102914 SH | 19 अगस्त 2026 | दैनिक |
| CURE · Direxion Shares ETF Trust | 0.13% | 947 NS | 31 जुलाई 2026 | N-PORT |
| DFSV · Dimensional ETF Trust | 0.12% | 42976 NS | 31 जुलाई 2026 | N-PORT |
| EQAL · Invesco Exchange-Traded Fund Trust … | 0.10% | 2764 SH | 1 अक्टूबर 2026 | दैनिक |
| IEUS · iShares Trust | 0.10% | 5579 SH | 11 सितमबर 2026 | दैनिक |
| IWR · iShares Trust | 0.10% | 200615 SH | 11 सितमबर 2026 | दैनिक |
| RECS · Columbia ETF Trust I | 0.10% | 23999 NS | 31 जुलाई 2026 | N-PORT |
| XOEF · iShares Trust | 0.07% | 61 SH | 11 सितमबर 2026 | दैनिक |
| DFUV · Dimensional ETF Trust | 0.06% | 41352 NS | 31 जुलाई 2026 | N-PORT |
| DXUV · Dimensional ETF Trust | 0.06% | 1302 NS | 31 जुलाई 2026 | N-PORT |
| DFAC · Dimensional ETF Trust | 0.05% | 106991 NS | 31 जुलाई 2026 | N-PORT |
| IVE · iShares Trust | 0.04% | 79930 SH | 11 सितमबर 2026 | दैनिक |
| IUSV · iShares Trust | 0.04% | 42675 SH | 11 सितमबर 2026 | दैनिक |
| SCZ · iShares Trust | 0.04% | 171786 SH | 11 सितमबर 2026 | दैनिक |
| VSS · VANGUARD INTERNATIONAL EQUITY INDEX… | 0.04% | 174824 SH | 19 अगस्त 2026 | दैनिक |
| VOOV · VANGUARD ADMIRAL FUNDS | 0.04% | 11139 SH | 19 अगस्त 2026 | दैनिक |
| DCOR · Dimensional ETF Trust | 0.04% | 5545 NS | 31 जुलाई 2026 | N-PORT |
| IWD · iShares Trust | 0.04% | 108791 SH | 11 सितमबर 2026 | दैनिक |
| CHRI · Global X Funds | 0.03% | 11 NS | 31 जुलाई 2026 | N-PORT |
| VONV · VANGUARD SCOTTSDALE FUNDS | 0.03% | 29579 SH | 19 अगस्त 2026 | दैनिक |
| PRF · Invesco Exchange-Traded Fund Trust | 0.03% | 9073 SH | 1 अक्टूबर 2026 | दैनिक |
| TOPC · iShares Trust | 0.03% | 32 SH | 11 सितमबर 2026 | दैनिक |
| DFSU · Dimensional ETF Trust | 0.02% | 2431 NS | 31 जुलाई 2026 | N-PORT |
| XVV · iShares Trust | 0.02% | 576 SH | 11 सितमबर 2026 | दैनिक |
| QVML · Invesco Exchange-Traded Fund Trust … | 0.02% | 1252 SH | 1 अक्टूबर 2026 | दैनिक |
| PBP · Invesco Exchange-Traded Fund Trust | 0.02% | 287 SH | 30 सितमबर 2026 | दैनिक |
| RWL · Invesco Exchange-Traded Fund Trust … | 0.02% | 7028 SH | 1 अक्टूबर 2026 | दैनिक |
| EGLE · Global X Funds | 0.02% | 2 NS | 31 जुलाई 2026 | N-PORT |
| IVV · iShares Trust | 0.02% | 607129 SH | 11 सितमबर 2026 | दैनिक |
| VOO · VANGUARD INDEX FUNDS | 0.02% | 1250774 SH | 19 अगस्त 2026 | दैनिक |
| VTI · VANGUARD INDEX FUNDS | 0.02% | 1530468 SH | 19 अगस्त 2026 | दैनिक |
| VONE · VANGUARD SCOTTSDALE FUNDS | 0.02% | 8168 SH | 19 अगस्त 2026 | दैनिक |
| VTHR · VANGUARD SCOTTSDALE FUNDS | 0.02% | 4112 SH | 19 अगस्त 2026 | दैनिक |
| ESGV · VANGUARD WORLD FUND | 0.02% | 11106 SH | 19 अगस्त 2026 | दैनिक |
| IWV · iShares Trust | 0.02% | 14165 SH | 11 सितमबर 2026 | दैनिक |
| IWB · iShares Trust | 0.02% | 33863 SH | 11 सितमबर 2026 | दैनिक |
| XRMI · Global X Funds | 0.02% | 41 NS | 31 जुलाई 2026 | N-PORT |
| DFAU · Dimensional ETF Trust | 0.02% | 9979 NS | 31 जुलाई 2026 | N-PORT |
| XYLD · Global X Funds | 0.02% | 2566 NS | 31 जुलाई 2026 | N-PORT |
| IYY · iShares Trust | 0.02% | 2018 SH | 11 सितमबर 2026 | दैनिक |
| ITOT · iShares Trust | 0.02% | 63582 SH | 11 सितमबर 2026 | दैनिक |
| PHDG · Invesco Actively Managed Exchange-T… | 0.02% | 38 SH | 1 अक्टूबर 2026 | दैनिक |
| PTLC · Pacer Funds Trust | 0.02% | 2492 NS | 31 जुलाई 2026 | N-PORT |
| TILT · FlexShares Trust | 0.02% | 1620 NS | 31 जुलाई 2026 | N-PORT |
| DFUS · Dimensional ETF Trust | 0.02% | 14645 NS | 31 जुलाई 2026 | N-PORT |
| XYLG · Global X Funds | 0.02% | 45 NS | 31 जुलाई 2026 | N-PORT |
| SPUU · Direxion Shares ETF Trust | 0.02% | 182 NS | 31 जुलाई 2026 | N-PORT |
| QDPL · Pacer Funds Trust | 0.02% | 1141 NS | 31 जुलाई 2026 | N-PORT |
| XTR · Global X Funds | 0.01% | 3 NS | 31 जुलाई 2026 | N-PORT |
| HCMT · Direxion Shares ETF Trust | 0.01% | 332 NS | 31 जुलाई 2026 | N-PORT |
| SPXL · Direxion Shares ETF Trust | 0.01% | 3766 NS | 31 जुलाई 2026 | N-PORT |
| IEUR · iShares Trust | 0.01% | 37473 SH | 11 सितमबर 2026 | दैनिक |
| XCLR · Global X Funds | 0.01% | 2 NS | 31 जुलाई 2026 | N-PORT |
| OMFL · Invesco Exchange-Traded Self-Indexe… | 0.01% | 1973 SH | 1 अक्टूबर 2026 | दैनिक |
| VGK · VANGUARD INTERNATIONAL EQUITY INDEX… | 0.01% | 110946 SH | 19 अगस्त 2026 | दैनिक |
| VT · VANGUARD INTERNATIONAL EQUITY INDEX… | 0.01% | 77796 SH | 19 अगस्त 2026 | दैनिक |
| VEA · VANGUARD TAX-MANAGED FUNDS | 0.01% | 447656 SH | 19 अगस्त 2026 | दैनिक |
| IDEV · iShares Trust | 0.01% | 52174 SH | 11 सितमबर 2026 | दैनिक |
| IEFA · iShares Trust | 0.00% | 272340 SH | 11 सितमबर 2026 | दैनिक |
| NEAR · iShares U.S. ETF Trust | 0.00% | 140000 SH | 9 सितमबर 2026 | दैनिक |
| DFLV · Dimensional ETF Trust | 0.00% | 377 NS | 31 जुलाई 2026 | N-PORT |
| IXUS · iShares Trust | 0.00% | 22623 SH | 11 सितमबर 2026 | दैनिक |
| VXUS · VANGUARD STAR FUNDS | 0.00% | 664961 SH | 19 अगस्त 2026 | दैनिक |
| VSGX · VANGUARD WORLD FUND | 0.00% | 8805 SH | 19 अगस्त 2026 | दैनिक |
| VGHY · VANGUARD FIXED INCOME SECURITIES FU… | · | · | 15 जुलाई 2026 | दैनिक |
| VCRB · VANGUARD MALVERN FUNDS | · | · | 15 जुलाई 2026 | दैनिक |
| VPLS · VANGUARD MALVERN FUNDS | · | · | 15 जुलाई 2026 | दैनिक |
| VSDB · VANGUARD MALVERN FUNDS | · | · | 15 जुलाई 2026 | दैनिक |
| VGMS · VANGUARD MALVERN FUNDS | · | · | 15 जुलाई 2026 | दैनिक |
| ISCB · iShares Trust | · | 2146 SH | 11 सितमबर 2026 | दैनिक |
| ISCV · iShares Trust | · | 10576 SH | 11 सितमबर 2026 | दैनिक |
| SMLF · iShares Trust | · | 18703 SH | 11 सितमबर 2026 | दैनिक |
CRL विश्लेषक सर्वसम्मति तेजी और मंदी के विश्लेषक राय, 12-महीने का मूल्य लक्ष्य, अपसाइड
रेटिंग · 23 विश्लेषक
खरीदें
मध्यिका लक्ष्य
$322.00
+11.0%
6 26.1%
मजबूत खरीद
11 47.8%
खरीदें
6 26.1%
होल्ड
0 0.0%
बेचें
0 0.0%
मजबूत बिक्री
12-महीने का मूल्य लक्ष्य
15 विश्लेषक · 2026-10-02माध्य लक्ष्य $305.00 +5.1%
अभी
वर्तमान मूल्य $290.19
निम्न$145.00
माध्य$305.00
उच्च$357.00
सहकर्मी तुलना (GICS उप-उद्योग) प्रमुख मेट्रिक्स बनाम सेक्टर के साथी
वित्तीय वर्ष के आधार पर, प्रत्येक कंपनी के पिछले वित्तीय वर्ष के अंत के बंद भाव के अनुसार कीमतें।
| टिकर | मार्केट कैप | P/E | राजस्व YoY | शुद्ध मार्जिन | ROE | सकल मार्जिन |
|---|---|---|---|---|---|---|
| CRL | $10.02B | -70.0 | -0.85% | -3.6% | -4.4% | · |
| WST | $19.81B | 40.5 | 6.2% | 16.1% | 16.2% | 35.9% |
| MEDP | $15.93B | 36.8 | 20.0% | 17.8% | 142.9% | · |
| RVTY | $10.86B | 46.7 | 3.7% | 8.5% | 3.3% | · |
| TEM | · | -41.9 | 83.4% | -19.3% | -61.2% | · |
| TEM | · | -41.9 | 83.4% | -19.3% | -61.2% | · |
| TXG | $2.08B | -46.6 | 5.2% | -6.8% | -5.5% | 69.0% |
| TECH | $11.03B | 60.9 | -0.38% | 15.0% | 9.0% | 65.8% |
| RGEN | $9.23B | 190.5 | 16.4% | 6.6% | 2.4% | · |
| AVTR | $7.82B | -14.7 | -3.4% | -8.1% | -8.9% | 32.6% |
| BIO | · | · | · | · | · | · |
ताज़ा समाचार इस कंपनी का उल्लेख करने वाली हालिया सुर्खियां
बायो-टेक्ने ने चार्ल्स रिवर लेबोरेटरीज इंटरनेशनल को पछाड़कर #477वां स्थान हासिल किया
Nasdaq · 3 months पहले
चार्ल्स रिवर लेबोरेटरीज इंटरनेशनल Q1 आय कॉल हाइलाइट्स
Yahoo Finance · 4 months, 3 weeks पहले
टोकनाइज्ड क्रिप्टो यूएस ट्रेजरी लगभग $14 बिलियन के करीब, क्योंकि सर्कल और ब्लैकरॉक विकास का नेतृत्व करते हैं।
Yahoo Finance · 5 months, 2 weeks पहले
मेरे मेट्रिक्स आपकी व्यक्तिगत वॉचलिस्ट — पूर्ण फंडामेंटल से चयनित पंक्तियाँ
उन मेट्रिक्स को चुनें जो आपके लिए मायने रखते हैं — ऊपर फुल फंडामेंटल्स में किसी भी पंक्ति के बगल में + पर क्लिक करें।
आपका चयन सहेजा गया है और यह सभी टिकर में आपके साथ रहता है।
स्रोत: SEC 10-Q अग 5, 2026 को फाइल किया गया